Novo Nordisk Invests $158 Million to Expand Brazil Insulin Plant

Novo Nordisk will invest $158.2 million to modernize its insulin plant in Montes Claros, Brazil. The investment will upgrade the factory and implement sustainability initiatives. This plant produces 25% of Novo Nordisk`s global insulin supply. The announcement coincided with a meeting between the Brazilian President and the Queen of Denmark.